Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
| Image |  |
|---|---|
| Description | scientific article published on 11 July 2017 |
| Author/s | |
| Publication date | July 12, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |